Detecting cancer
AssigneeUCL Business PLC
InventorsSamuel GAMBLE, James READING, Sam JANES, Maxine TRAN, Vitor TEIXEIRA, Claudia PEINADOR
Life of this patent
Estimating the term…
Loading patent…
AssigneeUCL Business PLC
InventorsSamuel GAMBLE, James READING, Sam JANES, Maxine TRAN, Vitor TEIXEIRA, Claudia PEINADOR
Estimating the term…
A method for determining whether a subject is at risk for having a progressing or high-grade pre-invasive lesion, nodule or small mass, or having a solid malignant tumour is described. The method involves analysing the proportion of T cells in a sample of blood obtained from the subject which are activated and/or exhausted T cells by analysing a trait of the T cells, e.g., via analysing biomarker expression using cytometry. In some instances, a plurality of traits is analysed and combined, e.g., via analysing biomarker expression using cytometry in combination with analysing the diversity or clonality of the blood TCR repertoire using TCR-seq.
1-38. (canceled)
A method of treating a subject determined to be at risk for having a progressing or high-grade pre-invasive lesion, nodule or small mass, or having a solid malignant tumour, the method comprising:
Dependencies are inferred from the claim text.